Gold-Standard RT-PCR Detection of SARS-CoV-2 at Rapid Speed: A Solution for Asymptomatic Screening
SARS-CoV-2 testing remains an essential tool as we seek to restore the health of communities globally. In 40–45% of cases, infection with SARS-CoV-2 does not lead to symptomatic disease, and it is estimated that up to 50% of new infections originate from exposure to individuals without symptoms. Screening tests are intended to identify infected individuals who may be contagious, regardless of whether they are displaying symptoms, so that measures can be taken to prevent those individuals from infecting others. Thus, screening of asymptomatic persons is critical to reducing transmission and enabling a safe return to work, school, and community activities.
Download this whitepaper to discover a SARS-CoV-2 test that:
- Is easy to use without the need for highly trained operators
- Provides results in less than an hour
- Has high sensitivity and specificity
